Punita Lal Joins Lupin Board as Additional Director
She has held senior positions at Coca-Cola in China and PepsiCo in India
She has held senior positions at Coca-Cola in China and PepsiCo in India
The company has posted net profit of Rs. 91.13 crores for the Financial Year ended March 31, 2025
For the full financial year FY25, revenue from operations grew 9 per cent to Rs. 11,537.8 crore, compared to Rs. 10,588 crore in FY24.
The company reported 30.1% jump in Q4 FY25 PAT at Rs. 1,222 crore
PAT stood at Rs. 88 crore for Q4 FY25 as compared to Rs. 56 crore in Q4FY24, an increase of 57%
Launched in Thailand, the ASEAN hub, marking an early entry into the fast-growing combination therapy market (DPP-4 and SGLT-2 inhibitor combination) with strong potential for market leadership
Scores highest PAT of Rs. 118 crore in FY25
ISPP will analyze health systems across states, identifying scalable models and actionable insights to strengthen India's healthcare delivery
This marks yet another milestone in our series of successful audits over the past year
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Subscribe To Our Newsletter & Stay Updated